86 related articles for article (PubMed ID: 1532232)
1. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.
Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
J Neurosci; 1989 Aug; 9(8):2710-7. PubMed ID: 2475591
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to cholinergic neurons in Alzheimer's disease.
Michaelson DM; Chapman J; Bachar O; Korczyn AD; Wertman E
Prog Clin Biol Res; 1989; 317():689-94. PubMed ID: 2602432
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.
Soussan L; Tchernakov K; Bachar-Lavi O; Yuvan T; Wertman E; Michaelson DM
Mol Neurobiol; 1994; 9(1-3):83-91. PubMed ID: 7888108
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons.
Faigon M; Hadas E; Alroy G; Chapman J; Auerbach JM; Michaelson DM
J Neurosci Res; 1991 Aug; 29(4):490-8. PubMed ID: 1791640
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease and Down's syndrome antibodies bind to the heavy neurofilament protein of cholinergic neurons.
Tchernakov K; Soussan L; Hassin-Baer S; Wertman E; Michaelson DM
Res Immunol; 1992; 143(6):670-5. PubMed ID: 1455060
[No Abstract] [Full Text] [Related]
7. Decreased density of forebrain cholinergic neurons and disintegration of the spatial organization of behavior in experimental autoimmune dementia (EAD).
Michaelson DM; Dubovik V; Faigon M; Eilam D; Feldon J
Ann N Y Acad Sci; 1993 Sep; 695():244-8. PubMed ID: 8239291
[TBL] [Abstract][Full Text] [Related]
8. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia.
Dubovik V; Faigon M; Feldon J; Michaelson DM
Neuroscience; 1993 Sep; 56(1):75-82. PubMed ID: 8232919
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an experimental autoimmune dementia model in the rat.
Michaelson DM; Alroy G; Goldstein D; Chapman J; Feldon J
Ann N Y Acad Sci; 1991; 640():290-4. PubMed ID: 1776754
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG brain reactive antibodies in Alzheimer disease and Down syndrome.
Kumar M; Cohen D; Eisdorfer C
Alzheimer Dis Assoc Disord; 1988; 2(1):50-5. PubMed ID: 2974704
[TBL] [Abstract][Full Text] [Related]
11. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.
Chapman J; Alroy G; Weiss Z; Faigon M; Feldon J; Michaelson DM
Neuroscience; 1991; 40(2):297-305. PubMed ID: 2027463
[TBL] [Abstract][Full Text] [Related]
12. Neuron-binding antibodies in Alzheimer's disease and Down's syndrome.
Franceschi M; Comola M; Nemni R; Pinto P; Iannaccone S; Smirne S; Canal N
J Gerontol; 1989 Jul; 44(4):M128-30. PubMed ID: 2525583
[TBL] [Abstract][Full Text] [Related]
13. Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.
Singh VK; Fudenberg HH
Autoimmunity; 1989; 3(2):95-101. PubMed ID: 2535254
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to neurofilaments.
Talja I; Reimand T; Uibo O; Reimand K; Aun S; Talvik T; Janmey PA; Uibo R
Ann N Y Acad Sci; 2009 Sep; 1173():130-6. PubMed ID: 19758141
[TBL] [Abstract][Full Text] [Related]
15. Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.
Oron L; Dubovik V; Novitsky L; Eilam D; Michaelson DM
J Neural Transm Suppl; 1997; 49():77-84. PubMed ID: 9266416
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to cholinergic neurons in Alzheimer's disease.
Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
J Neurochem; 1988 Aug; 51(2):479-85. PubMed ID: 3292704
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease.
Bajo M; Yoo BC; Cairns N; Gratzer M; Lubec G
Amino Acids; 2001; 21(3):293-301. PubMed ID: 11764410
[TBL] [Abstract][Full Text] [Related]
18. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
19. Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with Down's syndrome.
Grossmann A; Kukull WA; Jinneman JC; Bird TD; Villacres EC; Larson EB; Rabinovitch PS
Neurobiol Aging; 1993; 14(2):177-85. PubMed ID: 8098135
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome individuals begin life with normal levels of brain cholinergic markers.
Kish S; Karlinsky H; Becker L; Gilbert J; Rebbetoy M; Chang LJ; DiStefano L; Hornykiewicz O
J Neurochem; 1989 Apr; 52(4):1183-7. PubMed ID: 2522539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
